Green light concerns generalised myasthenia gravis therapy
Company is focused on endocannabinoid system treatments
A molecule sourced from funnel web spider venom shows promise as a safe and effective future drug for […]
License agreement concerns development of cell therapies for corneal blindness
Data supports Poolbeg’s strategic expansion of POLB 001
EUR 20m to identify new targets and develop first in class drugs
Aston University to create the Aston Institute for Membrane Excellence
Updated Date: Mon, 08 Jan 2024 00:00:00 EST
CellVoyant’s platform combines AI with live cell imaging
Companies collaborate to launch walk-in pain clinic